Age-related immunoreactivity pattern in medulloblastoma.

Area of Science:

• Neuropathology
• Pediatric Oncology
• Cancer Research

Background:

• Medulloblastomas are common pediatric brain tumors with diverse subtypes.
• Understanding the immunophenotype of medulloblastomas aids in diagnosis and prognosis.
• Previous studies have explored various markers, but age-related expression requires further investigation.

Purpose of the Study:

• To investigate the expression of glial fibrillary acidic protein (GFAP), cytokeratins (KL1, MNF116), desmin, and vimentin in medulloblastomas.
• To determine the significance of cytokeratin expression in relation to patient age and tumor maturity.
• To assess the presence of mesenchymal differentiation markers.

Main Methods:

• Paraffin-embedded medulloblastoma tissues from 35 patients (children and adults) were analyzed.
• Immunohistochemistry was performed using antibodies against GFAP, cytokeratins KL1 and MNF116, desmin, and vimentin.
• Reactions were evaluated to assess protein expression in tumor cells.

Main Results:

• Cytokeratin positivity was observed only in the tumor of the youngest patient (152-day-old boy), suggesting immaturity.
• Glial fibrillary acidic protein (GFAP) showed positivity in scattered astrocytes and, in two cases, in neoplastic cells.
• Vimentin was expressed in six tumors, with varying intensity and patterns. Desmin was not detected in any case.

Conclusions:

• Cytokeratin expression in medulloblastomas is age-dependent and indicative of tumor immaturity.
• GFAP and vimentin expression can be present but are not universal markers in medulloblastomas.
• The absence of desmin confirms that mesenchymal differentiation is rare and limited to medullomyoblastomas.